======= AGPAT5 ======= == Gene Information == * **Official Symbol**: AGPAT5 * **Official Name**: 1-acylglycerol-3-phosphate O-acyltransferase 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55326|55326]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9NUQ2|Q9NUQ2]] * **Interactions**: [[https://thebiogrid.org/search.php?search=AGPAT5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20AGPAT5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614796|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone. Acts on LPA containing saturated or unsaturated fatty acids C15:0-C20:4 at the sn-1 position using C18:1-CoA as the acyl donor. Also acts on lysophosphatidylethanolamine using oleoyl-CoA, but not arachidonoyl-CoA, and lysophosphatidylinositol using arachidonoyl-CoA, but not oleoyl-CoA. Activity toward lysophosphatidylglycerol not detectable. {ECO:0000269|PubMed:21173190}. |Acyltransferase| |CDP-diacylglycerol biosynthetic process| |CDP-diacylglycerol metabolic process| |1-acylglycerol-3-phosphate O-acyltransferase activity| |transferase activity, transferring acyl groups| |phosphatidic acid biosynthetic process| |phosphatidic acid metabolic process| |pyrimidine nucleotide biosynthetic process| |pyrimidine-containing compound biosynthetic process| |pyrimidine nucleotide metabolic process| |hematopoietic progenitor cell differentiation| |acylglycerol metabolic process| |neutral lipid metabolic process| |pyrimidine-containing compound metabolic process| |mitochondrial outer membrane| |nuclear envelope| |glycerophospholipid biosynthetic process| |glycerolipid biosynthetic process| |nucleotide biosynthetic process| |phospholipid biosynthetic process| |nucleoside phosphate biosynthetic process| |glycerophospholipid metabolic process| |phospholipid metabolic process| |glycerolipid metabolic process| |nucleotide metabolic process| |nucleoside phosphate metabolic process| |organophosphate biosynthetic process| |nucleobase-containing small molecule metabolic process| |hemopoiesis| |lipid biosynthetic process| |hematopoietic or lymphoid organ development| |immune system development| |organophosphate metabolic process| |endoplasmic reticulum membrane| |cellular lipid metabolic process| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |lipid metabolic process| |mitochondrion| |organic cyclic compound biosynthetic process| |organonitrogen compound biosynthetic process| |cellular nitrogen compound biosynthetic process| |small molecule metabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp1|5-Fluorouracil 2μM R00 exp1]]|1.72| |[[:results:exp461|BS-181 20μM R08 exp461]]|1.96| |[[:results:exp246|UM0011500 10μM R05 exp246]]|2.4| ^Gene^Correlation^ |[[:human genes:c:clpx|CLPX]]|0.442| |[[:human genes:c:ccdc90b|CCDC90B]]|0.437| |[[:human genes:m:mpv17l2|MPV17L2]]|0.422| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 1491 * **Expression level (log2 read counts)**: 6.77 {{:chemogenomics:nalm6 dist.png?nolink |}}